# Convergence and divergence of molecular mechanisms in Hebbian and homeostatic plasticity

**Authors:** Kira M. Feighan, Harshit K. Thakare, Stephen D. Glasgow, Timothy E. Kennedy

PMC · DOI: 10.3389/fnsyn.2026.1761008 · Frontiers in Synaptic Neuroscience · 2026-02-09

## TL;DR

This paper reviews how similar and different molecular mechanisms are used in two types of brain plasticity that help with learning and maintaining stable brain activity.

## Contribution

The paper systematically compares molecular mechanisms of Hebbian and homeostatic plasticity, highlighting convergent and divergent pathways.

## Key findings

- Homeostatic and Hebbian plasticity share some molecular mechanisms for regulating AMPARs.
- Divergent mechanisms uniquely regulate homeostatic synaptic scaling.
- Gaps remain in understanding how these mechanisms differentially impact AMPAR function.

## Abstract

The umbrella of synaptic plasticity includes associative, activity-dependent alterations in synaptic strength that are thought to underlie learning and memory, and negative feedback that stabilizes network activity, termed Hebbian and homeostatic plasticity, respectively. These forms of plasticity respond to activity oppositely, and on different spatial and temporal scales. However, despite these fundamental differences, many similar molecular mechanisms are engaged by each form of plasticity to alter synaptic strength. Here, we review molecular mechanisms involved in homeostatic plasticity and compare their involvement in Hebbian plasticity. We focus on synaptic scaling, long-term potentiation, and long-term depression, which are mediated by regulation of post-synaptic amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor (AMPARs) accumulation. Addressing synaptic scaffolding, intracellular signaling, cell-adhesion, and secreted factors, we identify mechanisms that appear to be convergent, differentially engaged, and divergent that uniquely regulate homeostatic scaling. These comparisons identify clear gaps to be addressed by future studies that aim to parse the contributions of Hebbian and homeostatic plasticity to regulate AMPAR function.

## Full-text entities

- **Genes:** Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Rarb (retinoic acid receptor, beta) [NCBI Gene 218772] {aka A830025K23, Hap, Nr1b2}, Mecp2 (methyl CpG binding protein 2) [NCBI Gene 17257] {aka 1500041B07Rik, D630021H01Rik, Mbd5, WBP10}, Camk4 (calcium/calmodulin-dependent protein kinase IV) [NCBI Gene 12326] {aka A430110E23Rik, CaMKIV, CaMKIV/Gr, D18Bwg0362e}, Sema3f (sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F) [NCBI Gene 20350] {aka Sema4, Semak}, Cdh1 (cadherin 1) [NCBI Gene 12550] {aka ARC-1, E-cad, Ecad, L-CAM, UVO, Um}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Nrp (neural regeneration protein) [NCBI Gene 654309], Sipa1l1 (signal-induced proliferation-associated 1 like 1) [NCBI Gene 217692] {aka 4931426N11Rik, Spar, mKIAA0440}, Epha4 (Eph receptor A4) [NCBI Gene 13838] {aka 2900005C20Rik, Cek8, Hek8, Sek, Sek1, Tyro1}, Rara (retinoic acid receptor, alpha) [NCBI Gene 19401] {aka Nr1b1, RAR, RARalpha1}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, Atp9b (ATPase, class II, type 9B) [NCBI Gene 50771] {aka Atpc2b, IIb, MMR}, Gusb (glucuronidase, beta) [NCBI Gene 110006] {aka Gur, Gus, Gus-r, Gus-s, Gus-t, Gus-u}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, Gria1 (glutamate receptor, ionotropic, AMPA1 (alpha 1)) [NCBI Gene 14799] {aka 2900051M01Rik, Glr-1, Glr1, GluA1, GluR-A, GluRA}, Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)) [NCBI Gene 14810] {aka GluN1, GluRdelta1, GluRzeta1, M100174, NMD-R1, NMDAR1}, Cacng2 (calcium channel, voltage-dependent, gamma subunit 2) [NCBI Gene 12300] {aka B230105C07Rik, B930041E13Rik, stargazer, stargazin, stg, wag}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Camk2a (calcium/calmodulin-dependent protein kinase II alpha) [NCBI Gene 12322] {aka CaMKII, mKIAA0968}, Plxna3 (plexin A3) [NCBI Gene 18846] {aka PlexA3, Plxa3, Plxn3, Plxn4, SEX, mKIAA4078}, Stx4a (syntaxin 4A (placental)) [NCBI Gene 20909] {aka Stx4, Syn-4, Syn4}, Nsf (N-ethylmaleimide sensitive fusion protein) [NCBI Gene 18195] {aka SKD2}, Grm5 (glutamate metabotropic receptor 5) [NCBI Gene 24418] {aka mGluR5, mGlur5}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Calm2 (calmodulin 2) [NCBI Gene 12314] {aka 1500001E21Rik, Cam2, CamC}, Plk2 (polo like kinase 2) [NCBI Gene 20620] {aka Snk}, Mecp2 (methyl CpG binding protein 2) [NCBI Gene 29386] {aka MECP2_e1}, Usp8 (ubiquitin specific peptidase 8) [NCBI Gene 84092] {aka Ubpy, mKIAA0055}, Nrp2 (neuropilin 2) [NCBI Gene 18187] {aka 1110048P06Rik, Np-2, Np2, Npn-2, Npn2}, Ppp2ca (protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform) [NCBI Gene 19052] {aka PP2A}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}, Ntrk2 (neurotrophic tyrosine kinase, receptor, type 2) [NCBI Gene 18212] {aka GP145-TrkB/GP95-TrkB, Tkrb, trk-B, trkB}, Npn2 (neoplastic progression 2) [NCBI Gene 18153] {aka HT/02}, Cdh2 (cadherin 2) [NCBI Gene 12558] {aka CDHN, N-CAD, Ncad}, Homer1 (homer scaffolding protein 1) [NCBI Gene 26556] {aka PSD-Zip45, SYN47, Ves-1, homer-1, vesl-1}, Lrpap1 (low density lipoprotein receptor-related protein associated protein 1) [NCBI Gene 16976] {aka HBP44, RAP}, Akap5 (A kinase anchor protein 5) [NCBI Gene 238276] {aka 3526401B18Rik, AKAP 150, AKAP-5, AKAP150, Gm258, P150}, Grm5 (glutamate receptor, metabotropic 5) [NCBI Gene 108071] {aka 6430542K11Rik, Glu5R, Gprc1e, mGluR5, mGluR5b}, Shank3 (SH3 and multiple ankyrin repeat domains 3) [NCBI Gene 58234] {aka Spank-2, proSAP2}, Akap5 (A-kinase anchoring protein 5) [NCBI Gene 171026] {aka AKAP150, Akap79, P150}, Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) [NCBI Gene 17999] {aka E430025J12Rik, EG639396, Gm7265, KIAA0093, Nedd4-1, Nedd4a}, B2m (beta-2 microglobulin) [NCBI Gene 12010] {aka Ly-m11, beta2-m, beta2m}, Fmr1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 14265] {aka FMRP, Fmr-1}, Stx3 (syntaxin 3) [NCBI Gene 20908] {aka Syn-3}, Gria1 (glutamate ionotropic receptor AMPA type subunit 1) [NCBI Gene 50592] {aka GluA1, gluR-A}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Grin2b (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 24410] {aka GluN2B}, Arc (activity regulated cytoskeletal-associated protein) [NCBI Gene 11838] {aka Arc3.1, arg3.1, mArc}, Gria2 (glutamate ionotropic receptor AMPA type subunit 2) [NCBI Gene 29627] {aka GluA2, GluR-K2, GluR2, gluR-B}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Rarg (retinoic acid receptor, gamma) [NCBI Gene 19411] {aka Nr1b3, RAR-gamma, RARD, RARgamma2}, Grip1 (glutamate receptor interacting protein 1) [NCBI Gene 74053] {aka 4931400F03Rik, GRIP, eb}, Tfap2a (transcription factor AP-2, alpha) [NCBI Gene 21418] {aka AP-2, AP2alpha, Ap-2 (a), Ap2, Ap2tf, Tcfap2a}, Pick1 (protein interacting with C kinase 1) [NCBI Gene 18693] {aka Prkcabp}, Rps6ka5 (ribosomal protein S6 kinase A5) [NCBI Gene 73086] {aka 3110005L17Rik, 6330404E13Rik, MSK1, MSPK1, RLPK, RLSK}, Mul1 (mitochondrial ubiquitin ligase activator of NFKB 1) [NCBI Gene 68350] {aka 0610009K11Rik, Gide, Tnrip-1}, Napb (N-ethylmaleimide sensitive fusion protein attachment protein beta) [NCBI Gene 17957] {aka Brp14, E161, I47, SNARE, b-SNAP}, Bace1 (beta-site APP cleaving enzyme 1) [NCBI Gene 23821] {aka ASP2, Bace}
- **Diseases:** AD (MESH:D000544), X-linked neurodevelopmental disorder (MESH:D038901), inflammatory (MESH:D007249), autism spectrum disorder (MESH:D000067877), hyperactivity (MESH:D006948), neurological disorders (MESH:D009461), seizure (MESH:D012640), LTD (MESH:D000088562), Rett syndrome (MESH:D015518), memory loss (MESH:D008569), depression (MESH:D003866), dysfunction (MESH:D006331)
- **Chemicals:** DHPG (MESH:C010117), picrotoxin (MESH:D010852), TTX (MESH:D013779), 2-amino-5-phosphonovaleric acid (MESH:D015763), glutamate (MESH:D018698), NMDA (MESH:D016202), bicuculline methiodide (MESH:C017069), fatty acids (MESH:D005227), BioRender (-), RA (MESH:D014212), bicuculline (MESH:D001640), calcium (MESH:D002118), NBQX (MESH:C062865)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** S831A, S421A, serine/threonine, Y876, S421, S845A, Y876F, M146V, S831, S295, S295A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926376/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926376/full.md

## References

287 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926376/full.md

---
Source: https://tomesphere.com/paper/PMC12926376